European Union Scientific Committee Says Monsanto's Posilac (rBGH) Should Not Be Used


Return to
Monsanto Investing News web page.

Here are the Conclusions and Recommendations of the Scientific Committee on Animal Health and Animal Welfare on the Animal Welfare Aspects of the Use of Bovine Somatotrophin (Adopted 10 March 1999). Looks like we agree with Canada!

Full text is on website
http://europa.eu.int/comm/dg24/health/sc/scah/out21_en.html

General conclusion

BST is used to increase milk yield, often in already high-producing cows. BST administration causes substantially and very significantly poorer welfare because of increased foot disorders, mastitis, reproductive disorders and other production related diseases. These are problems which would not occur if BST were not used and often results in unnecessary pain, suffering and distress. If milk yields were achieved by other means which resulted in the health disorders and other welfare problems described above, these means would not be acceptable. The injection of BST and its repetition every 14 days also causes localised swellings which are likely to result in discomfort and hence some poor welfare Recommendation BST use causes a substantial increase in levels of foot problems and mastitis and leads to injection site reactions in dairy cows. These conditions, especially the first two, are painful and debilitating, leading to significantly poorer welfare in the treated animals. Therefore from the point of view of animal welfare, including health, the Scientific Committee on Animal Health and Animal Welfare is of the opinion that BST should not be used in dairy cows.